Skip to main content

Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

R-EPOCH regimen

View Patient Information

A regimen consisting of rituximab, followed by a continuous infusion of etoposide, vincristine and doxorubicin, given with prednisone and a bolus dose of cyclophosphamide, used for the treatment of aggressive forms of non-Hodgkin's lymphoma, including mantle cell lymphoma.

Check for active clinical trials using this agent View this agent in the NCI Thesaurus

Synonym:	REPOCH regimen rituximab-EPOCH regimen rituximab-etoposide-prednisone-Oncovin-cyclophosphamide-hydroxydaunorubicin regimen rituximab/etoposide/prednisone/vincristine/cyclophosphamide/doxorubicin regimen

R-EPOCH regimen

Search NCI's Drug Dictionary